About CHRO
Over the past 35 years, the CHRO international conferences have been held around the world with the world's leading authorities in the field. This international workshop, started in 1981, is an international forum dedicated to enhancing the knowledge of this fascinating group of bacterial pathogens. Campylobacter jejuni is now firmly established as a major cause of bacterial diarrhea in both developed and developing countries. C. jejuni is also one of the major causes of the Guillain-Barre syndrome and continues attracting intense investigation worldwide. Genomic/proteomic/glycomic research on pathogens has made important strides on understanding disease pathogenesis and biology and the organism. At the 2nd workshop in Brussels in 1983, Helicobacter pylori was introduced to the world and the microbiological revolution of gastroduodenal disease began. The association of H. pylori with gastritis, peptic ulcers and gastric carcinoma is now universally recognized. An understanding of the disease process involving H. pylori and hopefully, the means to prevent or control appears to be within reach as a great many scientists and clinicians are striving towards this end. In recognition of the importance of H. pylori, Barry Marshall and Robin Warren were awarded the Nobel Prize in Medicine in 2005 for their discoveries and both of them remains very active with CHRO meetings and gave a keynote address at the past CHRO meeting in Niigata, Japan in 2009 and Belfast, UK in 2019. CHRO meetings have, and continue to be, the major venue for presenting research findings on Campylobacter and Helicobacter. The CHRO meetings focus on understanding the natural history, pathogenesis, and host and immunological responses to infection by Campylobacter and Helicobacter. CHRO is a major venue for presenting new work on developing vaccines for these infections. The CHRO conference aims to gather junior and senior investigators worldwide whose research encompassing all aspects of disease due to Campylobacter, Helicobacter and related organisms including microbial pathogenesis, genomics/proteomics/glycomics, immunology of infections, gastrointestinal pathophysiology, clinical management, public health, food safety, and human and animal ecology. The conference present overviews and updates in these diverse areas by keynote speakers who are experts in their field both inside the field, and encourage researchers present the latest results in these diverse areas during poster sessions and short talks. CHRO conference also aim to foster new collaborative multi-disciplinary interactions to address pressing questions of pathogenesis, prevention and treatment of diseases due to these pathogens and encourage young scientists to become actively involved in research on Campylobacter and Helicobacter.